A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: a randomized trial.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/15447697
Conclusion of this study
Riboflavin 25 mg showed an effect comparable to a combination of riboflavin 400 mg, magnesium 300 mg, and feverfew 100 mg. The placebo response exceeds that reported for any other placebo in trials of migraine prophylaxis, and suggests that riboflavin 25 mg may be an active comparator. There is at present conflicting scientific evidence with regard to the efficacy of these compounds for migraine prophylaxis.
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study